Stock AHEALTH APEX HEALTHCARE
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Apex Healthcare

Equities

AHEALTH

MYL7090OO003

End-of-day quote BURSA MALAYSIA
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
3.3 MYR -0.30% Intraday chart for Apex Healthcare +8.91% +32.53%
Apr. 15 Apex Healthcare Berhad Proposes the Special Dividend for the Financial Year Ended 31 December 2023 CI
Feb. 22 Apex Healthcare Boosts Dividend Despite Profit Decline in Q4 MT

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • The company is in a robust financial situation considering its net cash and margin position.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
  • The company benefits from high valuations in earnings multiples.
  • The company is highly valued given the cash flows generated by its activity.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Pharmaceuticals

1st Jan change Capi. Investor Rating ESG Refinitiv
APEX HEALTHCARE Stock Apex Healthcare
+32.53% 497M -
MCKESSON CORPORATION Stock McKesson Corporation
+14.53% 69.68B
C+
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+7.11% 8.21B
B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.55% 7.96B
B-
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
-4.06% 7.75B
C
H. LUNDBECK A/S Stock H. Lundbeck A/S
+2.14% 4.64B
B-
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.32B
B+
EBOS GROUP LIMITED Stock EBOS Group Limited
-1.24% 4.09B
B-
GALENICA AG Stock Galenica AG
-2.82% 3.82B
B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+21.42% 3.62B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. AHEALTH Stock
  4. Ratings Apex Healthcare